Donna Neuberg

101.3k citations

719 papers · 46.3k indexed · 16 hit papers · h-index 113

Impact in

Hematology top 0.01%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
Genetics top 0.02%
- Chronic Lymphocytic Leukemia Research

Papers in

Genetics 204
- Chronic Lymphocytic Leukemia Research 144
Hematology 206
- Acute Myeloid Leukemia Research 118
- Chronic Myeloid Leukemia Treatments 60
- Hematopoietic Stem Cell Transplantation 47

Co-authors: Margaret A. Shipp John G. Gribben Jeffery L. Kutok Jerome Ritz Lewis B. Silverman Stephen E. Sallan Kristen E. Stevenson A. Thomas Look
Journals: Blood (245 papers)Journal of Clinical Oncology (67 papers)Clinical Cancer Research (23 papers)Blood Advances (21 papers)Cancer (21 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

Donna Neuberg

702 papers receiving 45.4k citations

Hit Papers

15 papers align trajectories log scale

Prediction of Risk for Myeloid Malignancy in Clonal Hematopoiesis 2023 · 139 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 NEJM Evidence
2017 New England Journal of Medicine
2016 Journal of Clinical Oncology
2014 Blood
2014 Blood
2012 Clinical Cancer Research
2011 New England Journal of Medicine
2010 Blood
2008 Proceedings of the National Academy of Sciences
2006 Proceedings of the National Academy of Sciences
2004 New England Journal of Medicine
2004 Blood
2003 Journal of Clinical Oncology
2002 Nature Medicine
2002 Cancer Cell
1991 New England Journal of Medicine

Peers

Countries citing papers authored by Donna Neuberg

Since Specialization

Citations

This map shows the geographic impact of Donna Neuberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Neuberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Neuberg more than expected).

Fields of papers citing papers by Donna Neuberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna Neuberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Neuberg. The network helps show where Donna Neuberg may publish in the future.

Co-authors

The 25 scholars most cited alongside Donna Neuberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Donna Neuberg Line = papers co-authored together Donna Neuberg links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Mitochondrial DNA Mutations as Natural Barcodes for Lineage Tracing of Murine Tumor Models Cancer Research ·Livius Penter, Elisa ten Hacken, Jackson Southard, Caleb A. Lareau, Leif S. Ludwig, Shuqiang Li, Donna Neuberg, Kenneth J. Livak, Catherine J. Wu	2022	6
2	Longitudinal Single-Cell Dynamics of Chromatin Accessibility and Mitochondrial Mutations in Chronic Lymphocytic Leukemia Mirror Disease History Cancer Discovery ·Livius Penter, Satyen H. Gohil, Caleb A. Lareau, Leif S. Ludwig, Erin M. Parry, Teddy Huang, Shuqiang Li, Wandi Zhang, Dimitri Livitz, Ignaty Leshchiner, Laxmi Parida, Gad Getz, Laura Z. Rassenti, Thomas J. Kipps, Jennifer R. Brown, Matthew S. Davids, Donna Neuberg, Kenneth J. Livak, Vijay G. Sankaran, Catherine J. Wu	2021	45
3	Feasibility of Ultra-High-Throughput Functional Screening of Melanoma Biopsies for Discovery of Novel Cancer Drug Combinations Clinical Cancer Research ·Adam A. Friedman, Yun Xia, Lorenzo Trippa, Long P. Le, Vivien Igras, Dennie T. Frederick, Jennifer A. Wargo, Kenneth K. Tanabe, Donald P. Lawrence, Donna Neuberg, Keith T. Flaherty, David E. Fisher	2017	5
4	Polymorphisms of Asparaginase Pathway and Asparaginase-Related Complications in Children with Acute Lymphoblastic Leukemia Clinical Cancer Research ·Mohsen Ben Tanfous, Bahram Sharif-Askari, Francesco Ceppi, Haithem Laaribi, Vincent Gagné, Julie Rousseau, Malgorzata Labuda, Lewis B. Silverman, Stephen E. Sallan, Donna Neuberg, Jeffery L. Kutok, Daniel Sinnett, Caroline Laverdière, Maja Krajinović	2014	50
5	Postinduction Dexamethasone and Individualized Dosing of Escherichia Coli L-Asparaginase Each Improve Outcome of Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia: Results From a Randomized Study—Dana-Farber Cancer Institute ALL Consortium Protocol 00-01 Journal of Clinical Oncology ·Lynda M. Vrooman, Kristen E. Stevenson, Jeffrey G. Supko, Jane O’Brien, Suzanne E. Dahlberg, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell, Kara M. Kelly, Jeffery L. Kutok, Caroline Laverdière, Steven E. Lipshultz, Bruno Michon, Marshall A. Schorin, Mary V. Relling, Harvey J. Cohen, Donna Neuberg, Stephen E. Sallan, Lewis B. Silverman	2013	227
6	Follicular Lymphoma Cells Induce Changes in T-Cell Gene Expression and Function: Potential Impact on Survival and Risk of Transformation Journal of Clinical Oncology ·Shahryar Kiaii, Andrew Clear, Alan G. Ramsay, Derek Davies, Ajanthah Sangaralingam, Abigail Lee, Maria Calaminici, Donna Neuberg, John G. Gribben	2013	80
7	Bim Polymorphisms: Influence on Function and Response to Treatment in Children with Acute Lymphoblastic Leukemia Clinical Cancer Research ·Vincent Gagné, Julie Rousseau, Malgorzata Labuda, Bahram Sharif-Askari, Ivan Brukner, Caroline Laverdière, Francesco Ceppi, Stephen E. Sallan, Lewis B. Silverman, Donna Neuberg, Jeffery L. Kutok, Daniel Sinnett, Maja Krajinović	2013	17
8	Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson Blood ·Joshua J. Field, Gene Lin, Maureen Okam, Elaine M. Majerus, Jeffrey R. Keefer, Onyinye Onyekwere, Ainsley Ross, Federico Campigotto, Donna Neuberg, Joel Linden, David G. Nathan	2013	72
9	Mutated BCR-ABL Generates Immunogenic T-cell Epitopes in CML Patients Clinical Cancer Research ·Ann Cai, Derin B. Keskin, David S. DeLuca, Anselmo Alonso, Wandi Zhang, Guang Lan Zhang, Naa Norkor Hammond, Valentina Nardi, Richard M. Stone, Donna Neuberg, John Sidney, Vladimir Brusić, Catherine J. Wu	2012	40
10	Changes in Cardiac Biomarkers During Doxorubicin Treatment of Pediatric Patients With High-Risk Acute Lymphoblastic Leukemia: Associations With Long-Term Echocardiographic Outcomes Journal of Clinical Oncology ·Steven E. Lipshultz, Tracie L. Miller, Rebecca E. Scully, Stuart R. Lipsitz, Nader Rifai, Lewis B. Silverman, Steven D. Colan, Donna Neuberg, Suzanne E. Dahlberg, Jacqueline Henkel, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell, Caroline Laverdière, Bruno Michon, Marshall A. Schorin, Stephen E. Sallan	2012	227
11	In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells Blood ·Giovanni Amabile, Robert S. Welner, César Nombela‐Arrieta, Anna Morena D’Alise, Annalisa Di Ruscio, Alexander K. Ebralidze, Yevgenya Kraytsberg, Min Ye, Olivier Kocher, Donna Neuberg, Konstantin Khrapko, Leslie E. Silberstein, Daniel G. Tenen	2012	160
12	Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia Clinical Cancer Research ·Jennifer R. Brown, Megan Hanna, Bethany Tesar, Lillian Werner, Nathalie Pochet, John M. Asara, Yaoyu E. Wang, Paola Dal Cin, Stacey M. Fernandes, Christina Thompson, Laura E. MacConaill, Catherine J. Wu, Yves Van de Peer, Mick Correll, Aviv Regev, Donna Neuberg, Arnold S. Freedman	2012	59
13	Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia Clinical Cancer Research ·Philip C. Amrein, Eyal C. Attar, Tak Takvorian, Ephraim P. Hochberg, Karen K. Ballen, K. Leahy, David C. Fisher, Ann S. LaCasce, Eric D. Jacobsen, Philippe Armand, Robert P. Hasserjian, Lillian Werner, Donna Neuberg, Jennifer R. Brown	2011	100
14	Molecular Ontogeny of Donor-Derived Follicular Lymphomas Occurring after Hematopoietic Cell Transplantation Cancer Discovery ·Oliver Weigert, Nadja Kopp, Andrew A. Lane, Akinori Yoda, Suzanne E. Dahlberg, Donna Neuberg, Anita Y. Bahar, Bjoern Chapuy, Jeffery L. Kutok, Janina A. Longtine, Frank C. Kuo, Terry Haley, Maura Salois, Timothy J. Sullivan, David C. Fisher, Edward A. Fox, Scott J. Rodig, Joseph H. Antin, David M. Weinstock	2011	64
15	Active Immunotherapy Induces Antibody Responses That Target Tumor Angiogenesis Cancer Research ·Jonathan D. Schoenfeld, Masahisa Jinushi, Yukoh Nakazaki, Daniel Wiener, Joosang Park, Robert J. Soiffer, Donna Neuberg, Martín C. Mihm, F. Stephen Hodi, Glenn Dranoff	2010	64
16	Joint Loss of PAX2 and PTEN Expression in Endometrial Precancers and Cancer Cancer Research ·Nicolas M. Monte, Kaitlyn A. Webster, Donna Neuberg, Gregory R. Dressler, George L. Mutter	2010	93
17	CpG Oligodeoxynucleotides Alter Lymphocyte and Dendritic Cell Trafficking in Humans Clinical Cancer Research ·W. Nicholas Haining, Jeffrey K. Davies, Holger Kanzler, Linda Drury, Thomas Brenn, John Evans, Jill Angelosanto, Steven Rivoli, Kate Russell, Suzanne George, Paul Sims, Donna Neuberg, Xiaochun Li, Jeffrey L. Kutok, Jeffrey Morgan, Patrick Y. Wen, George D. Demetri, Robert L. Coffman, Lee M. Nadler	2008	61
18	Phase III Trial of Fludarabine Plus Cyclophosphamide Compared With Fludarabine for Patients With Previously Untreated Chronic Lymphocytic Leukemia: US Intergroup Trial E2997 Journal of Clinical Oncology ·Ian W. Flinn, Donna Neuberg, Michael R. Grever, Gordon W. Dewald, John M. Bennett, Elisabeth Paietta, Mohamad A. Hussein, Frederick R. Appelbaum, Richard A. Larson, Dennis F. Moore, Martin S. Tallman	2007	300
19	Cytotoxic T cells generated against heteroclitic peptides kill primary tumor cells independent of the binding affinity of the native tumor antigen peptide Blood ·Katja Zirlik, David Zahrieh, Donna Neuberg, John G. Gribben	2006	31
20	Disruption of the Jnk2 (Mapk9) gene reduces destructive insulitis and diabetes in a mouse model of type I diabetes Proceedings of the National Academy of Sciences ·Anja Jaeschke, Mercedes Rincón, Beth Doran, Judith Reilly, Donna Neuberg, Dale L. Greiner, Leonard D. Shultz, Aldo A. Rossini, Richard A. Flavell, Roger J. Davis	2005	74

About Donna Neuberg

Donna Neuberg is a scholar working on Genetics, Hematology, Pathology and Forensic Medicine, Immunology and Oncology, having authored 719 papers that have together received 46.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (154 papers), Chronic Lymphocytic Leukemia Research (144 papers), Acute Lymphoblastic Leukemia research (129 papers), Acute Myeloid Leukemia Research (118 papers), Chronic Myeloid Leukemia Treatments (60 papers), Immune Cell Function and Interaction (57 papers), Childhood Cancer Survivors' Quality of Life (54 papers) and Hematopoietic Stem Cell Transplantation (47 papers). The work is most often cited by research in Hematology (12.4k citations), Genetics (9.4k citations), Pathology and Forensic Medicine (11.3k citations), Oncology (14.0k citations) and Immunology (9.5k citations). Donna Neuberg has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Margaret A. Shipp, John G. Gribben, Jeffery L. Kutok, Jerome Ritz, Lewis B. Silverman, Stephen E. Sallan, Kristen E. Stevenson, A. Thomas Look, Scott J. Rodig and Benjamin L. Ebert. Their work appears in journals such as Blood, Journal of Clinical Oncology, Clinical Cancer Research, Blood Advances and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact